e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled granulocyte–macrophage colony-stimulating factor for
Mycobacterium abscessus
in cystic fibrosis
John P. Scott, Yinduo Ji, Mathur Kannan, Mark E. Wylam
Source:
Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017
Journal Issue:
April
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
John P. Scott, Yinduo Ji, Mathur Kannan, Mark E. Wylam. Inhaled granulocyte–macrophage colony-stimulating factor for
Mycobacterium abscessus
in cystic fibrosis. Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis
Source: Eur Respir J 2006; 27: 585-593
Year: 2006
Plasmapheresis for treatment of pulmonary alveolar proteinosis
Source: Eur Respir J 2009; 33: 1220-1222
Year: 2009
Granulocyte-macrophage colony stimulating factor inhalation therapy as a treatment for pulmonary alveolar proteinosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003
Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis
Source: Eur Respir J 2016; 47: 990-993
Year: 2016
Efficacy of aerosolized granulocyte-macrophage colony stimulating factor (GM-CSF) in a Japanese female patient with pulmonary alveolar proteinosis (PAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001
Alveolar lipoproteinosis syndromes
Source: Eur Respir Mon 2011; 54: 171-186
Year: 2011
Rituximab therapy in autoimmune pulmonary alveolar proteinosis
Source: Eur Respir J 2009; 33: 1503-1506
Year: 2009
Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation
Source: Eur Respir J 2013; 41: 433-442
Year: 2013
Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD
Source: Eur Respir J 2008; 32: 25-34
Year: 2008
Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013
Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis
Source: Short video statement 2020
Year: 2020
A patient with cystic fibrosis and Mycobacterium abscessus infection
Source: International Congress 2018 – CC1 Lung transplantation
Year: 2018
Increased vascular endothelial growth factor in acute eosinophilic pneumonia
Source: Eur Respir J 2003; 21: 774-778
Year: 2003
Immune defects in patients with pulmonary
Mycobacterium abscessus
disease without cystic fibrosis
Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020
Year: 2020
Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001
Pulmonary alveolar proteinosis and
Mycobacterium abscessus
lung infection related to ruxolitinib after allogeneic stem cell transplantation
Source: Eur Respir J, 51 (5) 1701960; 10.1183/13993003.01960-2017
Year: 2018
Successful treatment by GMCSF of pulmonary alveolar proteinosis relapsing after a first GMCSF course
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004
Validation of a new serum granulocyte–macrophage colony-stimulating factor autoantibody testing kit
Source: ERJ Open Res, 6 (1) 00259-2019; 10.1183/23120541.00259-2019
Year: 2020
Granulocyte colony-stimulating factor enhances the anticancer effects of cisplatin against lung cancer by promoting angiogenesis
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis
Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept